Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Brain Neoplasms × atezolizumab × Clear all

Phase

Phase 2 3 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 18 Carcinoma, Hepatocellular 12 Small Cell Lung Carcinoma 9 Triple Negative Breast Neoplasms 7 Neoplasms 7 Breast Neoplasms 6 Urinary Bladder Neoplasms 4 Ovarian Neoplasms 4 Lung Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Renal Cell 4 Carcinoma, Transitional Cell 3 Melanoma 2 Colonic Neoplasms 2 Carcinoma 2 Venous Thrombosis 1 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Squamous Non-Small Cell Lung Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Diseases 1 Rectal Neoplasms 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Neoplasms 1 Peritoneal Neoplasms 1 Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer 1 Non-Squamous Non-Small Cell Lung Cancer 1 Non-Small-Cell Lung 1 Non Small Cell Lung Cancer Metastatic 1 Neoplasms by Site 1

Interventions

Radiosurgery 21 Radiotherapy 20 Temozolomide 16 Lomustine 9 Bevacizumab 7 Surgical Procedures, Operative 6 Procarbazine 6 Vincristine 5 Nivolumab 5 Memantine 4 Filgrastim 4 Etoposide 4 Cisplatin 4 Carboplatin 4 Sodium Chloride 3 Radiation 3 Methylphenidate 3 Magnetic Resonance Spectroscopy 3 Granulocyte Colony-Stimulating Factor 3 Gefitinib 3 Cyclophosphamide 3 Corticotropin-Releasing Hormone 3 Carmustine 3 icotinib 2 etoposide phosphate 2 efaproxiral 2 X-Rays 2 Tranexamic Acid 2 Tf-CRM107 2 Specimen Handling 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05317858 2025-12-10

LIMITLESS

InSightec

Phase 3 Recruiting

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡